HDAC2 and breast neoplasm: Survival analyses of OS and RFS showed that the combined expression level of LSD1, HDAC2 and SIRT1 in breast tumors was more predictive for patient survival and tumor relapse than each of the individual markers separately in both univariate and multivariate analyses (Figure 5).